Quince Therapeutics, Inc. (IRLA)
IRulya Therapeutics is a clinical-stage biopharmaceutical company developing LAM-001, an inhaled formulation of rapamycin, for pulmonary diseases. Its clinical programs target pulmonary hypertension associated with interstitial lung disease, bronchiolitis obliterans syndrome after lung transplant, and sarcoidosis-associated pulmonary hypertension.
Sector: Biological Products, (No Diagnostic Substances)
Industry: Biotechnology
IRulya Therapeutics Inc.
NASDAQ:IRLAHealthcare · Biotechnology
-5.14%$31.38
AH Close$31.38+0.00%vs close
AH Close$31.38+0.00%vs close
Mkt Cap$31.92M
Float1.93M
O/S1.02M
Inst Own32.5%
Dilution
Delisting Issues Timeline
Financials Summary
Revenue$0
Net Income-$83.98M
Total Assets$93.52M
Free Cash Flow-$41.78M
Debt & Equity
Total Debt$18.47M
Total Equity-$35.71M
Shares Outstanding
Short Interest
Split History
No splits on record
Nothing in IRLA's public trading history: no forward or reverse split has affected the share count.
Balance Sheet Details
Assets$93.52M
Liabilities$129.24M
Accounts Receivable$3.62M
Accounts Payable$2.22M
Inventory$0
PP&E (Net)$1.05M
Goodwill$0
Intangible Assets$67.82M
Income Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 |
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| YoY Growth | - | - | - | - | - | - | - | - | - |
| Cost of Revenue | $142K | $0 | $0 | $0 | $0 | $0 | $0 | $51K | $45K |
| Gross Profit | -$142K | $0 | $0 | $0 | $0 | $0 | $0 | -$51K | -$45K |
| Gross Margin | - | - | - | - | - | - | - | - | - |
| Research and Development | $35.38M | $18.59M | $9.45M | $25.18M | $60.8M | $61.31M | $30.21M | $10.09M | $9.1M |
| Selling, General, and Administrative | $15.05M | $17.58M | $17.7M | $26.01M | $29.52M | $17.59M | $8.95M | $2.03M | $1.27M |
| Other | -$142K | $21.11M | $7.48M | $825K | $0 | $0 | $0 | $0 | $0 |
| Total Operating Expenses | $50.29M | $57.28M | $34.62M | $52.02M | $90.32M | $78.89M | $39.17M | $12.12M | $10.37M |
| Operating Income (EBIT) | -$50.43M | -$57.28M | -$34.62M | -$52.02M | -$90.32M | -$78.89M | -$39.17M | -$12.12M | -$10.37M |
| Operating Margin | - | - | - | - | - | - | - | - | - |
| Interest Expense | $0 | $0 | $0 | $568K | $0 | $0 | $0 | $957K | $1.64M |
| Interest Income | $1.24M | $2.93M | $3.48M | $1.07M | $620K | $2.04M | $2.19M | $806K | $0 |
| Other Income (Expense) | -$30.34M | $544K | $3.04M | $71K | $373K | $2.04M | $2.19M | -$357K | -$1.86M |
| Income Before Tax (EBT) | -$80.77M | -$56.74M | -$31.58M | -$51.94M | -$89.94M | -$76.85M | -$36.98M | -$12.48M | -$12.23M |
| Income Tax Expense | $3.21M | $87K | -$197K | -$284K | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$83.98M | -$56.83M | -$31.39M | -$51.66M | -$89.94M | -$76.85M | -$36.98M | -$12.48M | -$12.23M |
| Net Income Margin | - | - | - | - | - | - | - | - | - |
| Supplementary Data | |||||||||
| EPS | -336.00 | -262.00 | -168.00 | -308.00 | -606.00 | -526.00 | -386.00 | -116.00 | -114.00 |
| Diluted EPS | -336.00 | -262.00 | -168.00 | -308.00 | -606.00 | -526.00 | -386.00 | -116.00 | -114.00 |
| Weighted Average OS | 250,485 | 216,311 | 186,186 | 167,483 | 148,593 | 145,881 | 95,160 | 107,756 | 107,756 |
| EBITDA | -$80.62M | -$35.98M | -$26.82M | -$50.99M | -$89.6M | -$78.56M | -$38.98M | -$12.07M | -$10.32M |
| EBITDA Margin | - | - | - | - | - | - | - | - | - |
Balance Sheet
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 |
| Assets | |||||||||
| Current Assets | |||||||||
| Cash and Cash Equivalents | $5.81M | $6.21M | $20.75M | $44.58M | $69.72M | $66.84M | $51.21M | $24.87M | $7.34M |
| Short-Term Investments | $11.94M | $34.57M | $54.31M | $45.6M | $37.08M | $66.98M | $48.65M | $46.84M | $0 |
| Cash and Short-Term Investments | $17.75M | $40.78M | $75.06M | $90.18M | $106.8M | $133.82M | $99.86M | $71.72M | $7.34M |
| Accounts Receivable | $3.62M | $882K | $993K | $0 | $1.13M | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Current Assets | $54K | $84K | $81K | $2.37M | $367K | $694K | $688K | $821K | $143K |
| Total Current Assets | $22.9M | $44.04M | $77.44M | $93.75M | $111.67M | $137.86M | $106.06M | $72.58M | $7.54M |
| Long-Term Assets | |||||||||
| Property, Plant & Equipment Net | $1.05M | $813K | $619K | $684K | $1.43M | $1.1M | $1.33M | $283K | $122K |
| Goodwill | $0 | $0 | $17.63M | $0 | $0 | $0 | $0 | $0 | $0 |
| Intangible Assets | $67.82M | $60.05M | $63.67M | $5.9M | $0 | $0 | $0 | $0 | $0 |
| Long-Term Investments | $78K | $78K | $78K | $3.58M | $19.93M | $50.46M | $16.76M | $0 | $0 |
| Deferred Tax Assets | $0 | $0 | $12.3M | -$3.58M | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Assets | $1.68M | $9.51M | $8.47M | $3.58M | $194K | $39K | $217K | $10K | $59K |
| Total Long-Term Assets | $70.63M | $70.44M | $102.76M | $10.16M | $21.55M | $51.6M | $18.31M | $293K | $181K |
| Other Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Assets | $93.52M | $114.48M | $180.2M | $103.91M | $133.23M | $189.47M | $124.37M | $72.88M | $7.72M |
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts Payable | $2.22M | $2.9M | $2.03M | $570K | $4.91M | $3.56M | $3.08M | $495K | $517K |
| Short-Term Debt | $18.03M | $0 | $64K | $0 | $0 | $0 | $0 | $0 | $0 |
| Current Income Tax Payable | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Current Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Current Liabilities | $12.58M | $308K | $5.13M | $916K | $180K | $10.79M | $0 | $0 | $0 |
| Total Current Liabilities | $43.23M | $7.28M | $9.57M | $3.07M | $14.22M | $17M | $8.89M | $1.46M | $1.76M |
| Long-Term Liabilities | |||||||||
| Long-Term Debt | $330K | $14.32M | $13.43M | $0 | $0 | $0 | $0 | $0 | $7.17M |
| Long-Term Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Deferred Tax Liabilities | $0 | $4.96M | $17.61M | $248K | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Liabilities | $85.68M | $57.38M | $54.19M | $0 | $0 | $0 | $0 | $0 | $19.06M |
| Total Long-Term Liabilities | $86.01M | $77.05M | $85.55M | $248K | $420K | $208K | $3.08M | $495K | $26.23M |
| Other Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | -$3.08M | -$495K | $0 |
| Total Liabilities | $129.24M | $84.33M | $95.12M | $3.32M | $14.64M | $17.2M | $8.89M | $1.46M | $28M |
| Stockholders' Equity | |||||||||
| Preferred Stock | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $104.05M | $17.18M |
| Common Stock | $55K | $44K | $43K | $36K | $30K | $29K | $27K | $22K | $3K |
| Retained Earnings | -$460.45M | -$376.47M | -$319.64M | -$288.26M | -$236.6M | -$146.65M | -$69.81M | -$32.83M | -$20.35M |
| Comprehensive Income & Other | $5.75M | -$35K | $3.05M | -$289K | -$79K | $313K | $60K | -$49K | -$17.18M |
| Other Stockholders' Equity | $424.68M | $406.57M | $404.69M | $388.82M | $355.15M | $318.89M | $185.26M | $104.22M | $66K |
| Total Equity | -$35.71M | $30.15M | $85.08M | $100.59M | $118.59M | $172.26M | $115.48M | $71.42M | -$20.28M |
| Minority Interest | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities and Equity | $93.52M | $114.48M | $180.2M | $103.91M | $133.23M | $189.47M | $124.37M | $72.88M | $7.72M |
| Supplementary Data | |||||||||
| Total Debt | $18.47M | $14.81M | $13.81M | $453K | $1.16M | $446K | $0 | $0 | $7.17M |
| Net Debt | $12.66M | $8.6M | -$6.94M | -$44.13M | -$68.56M | -$66.39M | -$51.21M | -$24.87M | -$172K |
Cash Flow Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 |
| Operating Activities | |||||||||
| Net Income | -$83.98M | -$56.83M | -$31.39M | -$51.66M | -$89.94M | -$76.85M | -$36.98M | -$12.48M | -$12.23M |
| Depreciation & Amortization | $142K | $186K | $322K | $204K | $344K | $332K | $188K | $51K | $45K |
| Deferred Income Tax | -$4.96M | $0 | -$248K | -$284K | $878K | $635K | -$812K | -$145K | $222K |
| Stock-Based Compensation | $5.11M | $4.75M | $5.22M | $16.62M | $29.85M | $14.47M | $2.06M | $155K | $38K |
| Changes in Working Capital: | |||||||||
| Accounts Receivable | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Accounts Payable | -$940K | $927K | -$288K | -$5.94M | $1.36M | $480K | $2.58M | -$23K | $223K |
| Other Working Capital | $13.78M | -$1.41M | $2.27M | -$3.89M | -$5.62M | $9.75M | -$676K | -$367K | $237K |
| Total Working Capital Change | $12.84M | -$484K | $1.98M | -$9.83M | -$4.26M | $10.23M | $1.9M | -$390K | $460K |
| Other Non-Cash Items | $29.43M | $20.48M | $5.82M | $913K | $199K | $367K | $367K | $1.11M | $1.64M |
| Net Cash from Operating | -$41.42M | -$31.9M | -$18.29M | -$44.04M | -$62.93M | -$50.82M | -$33.28M | -$11.7M | -$9.83M |
| Investing Activities | |||||||||
| Capital Expenditures | -$352K | -$257K | -$160K | -$133K | -$180K | -$52K | -$55K | -$212K | -$77K |
| Acquisitions | $0 | $0 | -$2.12M | $10.59M | -$58.95M | $52.43M | -$812K | $0 | $0 |
| Purchases of Investments | -$34.42M | -$89.56M | -$113.78M | -$75.02M | -$38.79M | -$187.14M | -$135.41M | -$55.24M | $0 |
| Sales of Investments | $56.98M | $109.38M | $111.21M | $82.49M | $97.92M | $134.76M | $117.72M | $8.7M | $0 |
| Other Investing Activities | $1.01M | $2.35M | -$910K | $70K | $58.95M | -$52.43M | $812K | -$46.54M | $0 |
| Net Cash from Investing | $23.23M | $21.91M | -$5.76M | $18M | $58.95M | -$52.43M | -$17.75M | -$46.75M | -$77K |
| Financing Activities | |||||||||
| Debt Repaid | - | - | $6K | $49K | - | $34K | $559K | -$250K | -$7.75M |
| Common Stock Issuance | $17.91M | $225K | $149K | $608K | $6.81M | $117.63M | $77.83M | $75.68M | $0 |
| Common Stock Repurchases | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Financing Activities | $0 | -$5M | $0 | $148K | $0 | $1.28M | $98K | -$10K | $0 |
| Net Cash from Financing | $17.91M | -$4.78M | $143K | $707K | $6.81M | $118.88M | $77.37M | $75.93M | $7.75M |
| Forex Effect | -$114K | $231K | $80K | $184K | $55K | $0 | $0 | $0 | $0 |
| Net Change in Cash | -$403K | -$14.54M | -$23.83M | -$25.14M | $2.88M | $15.63M | $26.34M | $17.48M | -$2.15M |
| Supplementary Data | |||||||||
| Operating Cash Flow | -$41.42M | -$31.9M | -$18.29M | -$44.04M | -$62.93M | -$50.82M | -$33.28M | -$11.7M | -$9.83M |
| Capital Expenditure | -$352K | -$257K | -$160K | -$133K | -$180K | -$52K | -$55K | -$212K | -$77K |
| Free Cash Flow | -$41.78M | -$32.16M | -$18.45M | -$44.17M | -$63.11M | -$50.87M | -$33.33M | -$11.91M | -$9.9M |
| Cash at Beginning | $6.21M | $20.75M | $44.58M | $69.72M | $66.84M | $51.21M | $24.87M | $7.39M | $9.55M |
| Cash at End | $5.81M | $6.21M | $20.75M | $44.58M | $69.72M | $66.84M | $51.21M | $24.87M | $7.39M |